Thierry Guillaume

4.4k citations

179 papers · 2.7k indexed · h-index 28

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 92
- Acute Myeloid Leukemia Research 35
Immunology top 5%
- Immune Cell Function and Interaction 25
- T-cell and B-cell Immunology 18
Oncology top 5%
- Polyomavirus and related diseases 22
- Viral-associated cancers and disorders 17
Transplantation top 5%
Genetics top 5%
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 24
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 17

Co-authors: Michel Symann Daniel B. Rubinstein Patrice Chevallier Philippe Moreau Mohamad Mohty Pierre Péterlin Florent Malard Alice Garnier
Cited by: Hematology Immunology Oncology
Journals: Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (4 papers)Blood (35 papers)
Partner nations: France Belgium United States

In The Last Decade

Thierry Guillaume

172 papers receiving 2.6k citations

Peers

Countries citing papers authored by Thierry Guillaume

Since Specialization

Citations

This map shows the geographic impact of Thierry Guillaume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Guillaume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Guillaume more than expected).

Fields of papers citing papers by Thierry Guillaume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Guillaume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Guillaume. The network helps show where Thierry Guillaume may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thierry Guillaume, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thierry Guillaume Line = papers co-authored together Thierry Guillaume links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial Blood Cancer Journal ·Éolia Brissot,Myriam Labopin,Hélène Labussière,Gaëlle Fossard,Patrice Chevallier,Thierry Guillaume,Ibrahim Yakoub‐Agha,Micha Srour,Claude‐Eric Bulabois,Anne Huynh,Sylvain Chantepie,Anne‐Lise Ménard,Marie‐Thérèse Rubio,Patrice Céballos,Rémy Duléry,Sabine Fürst,Florent Malard,Didier Blaise,Mohamad Mohty	2024	12
2	Tocilizumab in combination with a standard induction chemotherapy in acute myeloid leukaemia patients (TOCILAM study): a single-centre, single-arm, phase 1 trial EClinicalMedicine ·Pierre Péterlin,Alice Garnier,Amandine Le Bourgeois,Thierry Guillaume,Yannick Le Bris,Olivier Theisen,Marie C. Béné,Marion Eveillard,Marie Rimbert,Maxime Jullien,Lucie Planche,Joëlle Gaschet,Patrice Chevallier	2023	5
3	Complications stomatologiques dans le contexte de l’allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) Bulletin du Cancer ·Laëtitia Souchet,Imran Ahmad,Fati Hamzy,Patrice Céballos,Yohann Desbrosses,Aurélie Ravinet,Pascal Turlure,Alban Villate,Émmanuelle Vigarios,Cécile Borel,Ibrahim Yakoub‐Agha,Thierry Guillaume	2020	1
4	Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) Bulletin du Cancer ·John De Vos,Étienne Baudoux,Jacques‐Olivier Bay,Boris Calmels,Audrey Cras,Jean El Cheikh,Marie-Agnès Guérout-Vérité,Marie-Noëlle Lacassagne,Sylvain Lamure,Catherine Letellier,Anne‐Lise Ménard,Étienne Daguindau,Xavier Poiré,Ibrahim Yakoub‐Agha,Thierry Guillaume	2018	11
5	Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients Biology of Blood and Marrow Transplantation ·Louise Bouard,Caroline Bodet‐Milin,Clément Bailly,Thierry Guillaume,Pierre Péterlin,Alice Garnier,Amandine Le Bourgeois,Beatrice Mahé,Viviane Dubruille,Nicolas Blin,Cyrille Touzeau,Thomas Gastinne,Anne Lok,Antoine Bonnet,Marie C. Béné,Steven Le Gouill,Philippe Moreau,Françoise Kraeber‐Bodéré,Patrice Chevallier	2018	3
6	Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas Annals of Hematology ·Benoît Tessoulin,P. Thomaré,E. Delande,J. Moynard,Thomas Gastinne,Philippe Moreau,Céline Bossard,Beatrice Mahé,Nicolas Blin,Viviane Dubruille,Cyrille Touzeau,Jean Samuel Boudreault,F. Perrin,Anne Lok,Thierry Guillaume,Alice Garnier,Pierre Péterlin,Pierre Gallas,Patrice Chevallier,Steven Le Gouill	2017	9
7	Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults Biology of Blood and Marrow Transplantation ·Pierre Péterlin,Jacques Delaunay,Thierry Guillaume,Thomas Gastinne,Beatrice Mahé,Viviane Dubruille,Nicolas Blin,Amandine Le Bourgeois,Éolia Brissot,Laurence Lodé,Steven Le Gouill,Philippe Moreau,Mohamad Mohty,Patrice Chevallier	2014	10
8	Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center Annals of Oncology ·Marion Loirat,Patrice Chevallier,Christophe Leux,Philippe Moreau,Céline Bossard,Thierry Guillaume,Thomas Gastinne,J. Delaunay,Nicolas Blin,Beatrice Mahé,Viviane Dubruille,Karine Augeul-Meunier,Pierre Péterlin,Hervé Maisonneuve,Nadine Juge‐Morineau,Henry Jardel,Mohamad Mohty,Steven Le Gouill	2014	30
9	Early detection of acute graft‐versus‐host disease by wireless capsule endoscopy and probe‐based confocal laser endomicroscopy: results of a pilot study United European Gastroenterology Journal ·Emmanuel Coron,Valérie Laurent,Florent Malard,Marc Le Rhun,Patrice Chevallier,Thierry Guillaume,Jean‐François Mosnier,Jean–Paul Galmiche,Mohamad Mohty	2014	13
10	Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial Haematologica ·Didier Blaise,Raynier Devillier,A.-G. Lecoroller-Sorriano,Jean‐Marie Boher,Agnès Boyer-Chammard,Reza Tabrizi,P. Chevallier,Nathalie Fegueux,Anne Sîrvent,Mauricette Michallet,Jacques Olivier Bay,S. Furst,Jean El Cheikh,Laure Vincent,Thierry Guillaume,Caroline Régny,Nöel Milpied,Luca Castagna,Mohamad Mohty	2014	18
11	Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults Experimental Hematology ·Amandine Le Bourgeois,Myriam Labopin,Thierry Guillaume,Jacques Delaunay,Yohann Foucher,Benoît Tessoulin,Florent Malard,Sameh Ayari,Pierre Péterlin,Sophie Derenne,Patricia Herry,Anne Cesbron,Katia Gagne,Laurence Lodé,Marina Illiaquer,Berthe‐Marie Imbert‐Marcille,Steven Le Gouill,Philippe Moreau,Mohamad Mohty,Patrice Chevallier	2014	11
12	Prospective Comparison Of Five Viral Infections (HHV6, CMV, EBV, ADV, BKv) After Umbilical Cord Blood (UCB) Vs PBSC Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation (allo-SCT) In Adults Blood ·Berthe‐Marie Imbert‐Marcille,Lucie Planche,Marie Rimbert,Claire Le Houérou,Céline Bressollette‐Bodin,Thierry Guillaume,Amandine Le Bourgeois,Jacques Delaunay,Philippe Moreau,Mohamad Mohty,Patrice Chevallier	2013	1
13	Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study Blood ·Patrice Chevallier,Nelly Robillard,Aude Charbonnier,Emmanuel Raffoux,Sébastien Maury,Sylvain Carras,Cécile Moluçon‐Chabrot,Cécile Fohrer,Marc Bernard,Jean‐Sébastien Blade,Anne Etienne,Pascaline Talmant,Jacques Delaunay,Thierry Guillaume,Mohamad Mohty,Marie C. Béné,Norbert Ifrah,Hervé Dombret	2012	11
14	Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation Leukemia ·Zinaida Perić,Xavier Cahu,Patrice Chevallier,Éolia Brissot,Florent Malard,Thierry Guillaume,J. Delaunay,Sameh Ayari,Viviane Dubruille,Steven Le Gouill,Beatrice Mahé,Thomas Gastinne,Nicolas Blin,Beatrice Saulquin,J-L Harousseau,Philippe Moreau,Nöel Milpied,Marianne Coste‐Burel,B-M Imbert-Marcille,Mohamad Mohty	2011	57
15	Re-administration of a combination of chemotherapy+Gemtuzumab at relapse in CD33+ AML patient allows to second remission and is feasible without extra toxicity Leukemia Research ·Patrice Chevallier,Cyrille Touzeau,Sameh Ayari,Thierry Guillaume,Jean‐Luc Harousseau,Jacques Delaunay	2007	2
16	Autologous peripheral blood stem cell transplantation for lung cancer Best Practice & Research Clinical Haematology ·Thierry Guillaume,Daniel B. Rubinstein,Ken S. Zaner,Yves Humblet,Michel Symann	1999	4
17	Retroviral-mediated gene transfer of human multidrug resistance associated murine hematopoietic cells British Journal of Haematology ·Jean‐Pascal Machiels,Véronique D’Hondt,Anne-Sophie Govaerts,Thierry Guillaume,Babak Bayat,Anne-Marie Feyens,Alexander Bank,Michel Symann	1998	1
18	Retroviral-mediated gene transfer of murine IL-12 into tumor cells and fibroblasts as a strategy to increase the host anti-tumor immune system Cancer Gene Therapy ·A-S. Govaerts,Marc André,Thierry Guillaume,Babak Bayat,Anne Marie Feyens,Michel Symann	1996	1
19	Tolerance and Effectiveness of Combined Il-3 and G-csf in Collecting Peripheral-blood Progenitor Cells (pbpc) Following Disease-oriented Chemotherapy Experimental Hematology ·Véronique D’Hondt,Yves Humblet,Thierry Guillaume,Chantal Doyen,Jean‐Claude Osselaer,Benjamin B. Mull,Michel Symann	1993	1
20	Restriction fragment length polymorphisms and single germline coding region sequence in VH182, a duplicated gene encoding autoantibody Molecular Immunology ·Daniel B. Rubinstein,Michel Symann,A. Keith Stewart,Thierry Guillaume	1993	16

About Thierry Guillaume

Thierry Guillaume is a scholar working on Hematology, Transplantation and Oncology, having authored 179 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (92 papers), Acute Myeloid Leukemia Research (35 papers), Immune Cell Function and Interaction (25 papers), Acute Lymphoblastic Leukemia research (24 papers), Polyomavirus and related diseases (22 papers), T-cell and B-cell Immunology (18 papers), Viral-associated cancers and disorders (17 papers) and Lymphoma Diagnosis and Treatment (17 papers). The work is most often cited by research in Hematology (1.4k citations), Immunology (885 citations) and Oncology (879 citations). Thierry Guillaume has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Michel Symann, Daniel B. Rubinstein, Patrice Chevallier, Philippe Moreau, Mohamad Mohty, Pierre Péterlin, Florent Malard, Alice Garnier, Viviane Dubruille and Beatrice Mahé. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact